Table 2.

Frequency of Kras mutations in ovarian serous borderline tumor (OSBT) and ovarian low grade serous carcinoma (OLGSCa)

OSBT	OLGSCa	Reference
36%	NA	Mok et al. [28]
35%	33%	Haas et al. [29]
33%	35%	Singer et al. [19]
22%	N/A	Mayr et al. [20]
18%	N/A	Anglesio et al. [21]
17%	19%	Wong et al. [22]
39.5%	23%	Vereczkey et al. [23]
N/A	54.5%	Sundov et al. [25]